INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,306,000 | +424.5% | 500,291 | +257.0% | 0.00% | – |
| Q3 2017 | $249,000 | +58.6% | 140,122 | +69.3% | 0.00% | – |
| Q2 2017 | $157,000 | -19.9% | 82,762 | -15.5% | 0.00% | – |
| Q1 2017 | $196,000 | -68.9% | 97,890 | -5.4% | 0.00% | -100.0% |
| Q4 2016 | $631,000 | -67.2% | 103,428 | -49.0% | 0.00% | -66.7% |
| Q3 2016 | $1,921,000 | +80.9% | 202,624 | +41.9% | 0.00% | +50.0% |
| Q2 2016 | $1,062,000 | +337.0% | 142,747 | +334.6% | 0.00% | – |
| Q1 2016 | $243,000 | +46.4% | 32,845 | +124.3% | 0.00% | – |
| Q4 2015 | $166,000 | – | 14,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |